Somatuline Autogel: Acromegaly Self/Partner Injection Study

Phase 4 Completed 30 enrolled Ipsen

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to allow patients with acromegaly, or their partners, to learn how to successfully inject Somatuline Autogel at home. Ability to perform unsupervised injections whilst maintaining adequate disease control will be assessed.

Timeline

Start: 2004-02
Primary completion: 2005-08-24
Completion: 2005-08-24

Publications

Results Bevan JS, Newell-Price J, Wass JA, Atkin SL, Bouloux PM, Chapman J, Davis JR, Howlett TA, Randeva HS, Stewart PM, Viswanath A. Home administration of lanreotide Autogel by patients with acromegaly, or their partners, is safe and effective. Clin Endocrinol (Oxf). 2008 Mar;68(3):343-9. doi: 10.1111/j.1365-2265.2007.03044.x. Epub 2007 Sep 24.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lanreotide	Other / unclassified	60 mg	—
Subject	Lanreotide	Other / unclassified	90 mg	—
Subject	Lanreotide	Other / unclassified	120 mg	—

Somatuline Autogel: Acromegaly Self/Partner Injection Study

Summary

Timeline

Publications

Drugs

Indications